Featured,Trends & Articles DEA and NIDA Supports White House Plan to Streamline Research on Marijuana and Psychedelics By Dennis Mutua December 08, 2021 The Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA) announced that they are in full support of a proposal by White House to streamline the research process on Schedule I drugs including mariju...
Spotlight Stock,Trends & Articles PharmaTher Granted New Japanese Patent For Ketamine Combined Fomulation By Dennis Mutua December 01, 2021 Clinical-stage biotechnology company specializing on development and commercialization of novel psychedelics pharmaceuticals PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) announced having been granted a new patent by the Jap...
Spotlight Stock,Trends & Articles Seelos Therapeutics Raises $20M in a Private Placement of Senior Secured Convertible Note By Dennis Mutua November 25, 2021 Clinical stage bio-pharmaceutical specializing in developing and advancing novel therapeutics to address unmet medical needs for patients suffering from central nervous (CNS) disorders and rare diseases Seelos Therapeutics Inc. (N...
Spotlight Stock,Trends & Articles COMPASS Pathways Receives Fifth U.S Patent For Crystalline Psilocybin By Dennis Mutua November 24, 2021 Mental healthcare company focusing of accelerating patient access to evidence-based in mental health COMPASS Pathways Plc. (NASDAQ: CMPS) announced having received its fifth patent from the United States Patent and Trademark Offic...
Featured,Trends & Articles Study Shows Psilocybin Has the Potential to Reverse Alcohol-Induced Brain Damage By Dennis Mutua November 23, 2021 A recently released study is indicating that psilocybin, a compound found in magic mushrooms has the ability to reverse alcohol induced brain damages. Additionally, psilocybin also has the potential to reduce cravings for alcohol ...
Spotlight Stock,Trends & Articles Filament Health Enters into a Co-Development and Licensing Agreement With EntheoTech By Dennis Mutua November 19, 2021 Exclusively natural psychedelics drug discovery and extraction company Filament Health Corp. (NEO: FE) (OTCQB: FLHLF) announced having entered into a co-development and exclusive licensing agreement with EntheoTech Bioscience Inc....
Featured,Trends & Articles MYND Diagnostics Begins Clinical Research on Alzheimer’s Disease By Dennis Mutua November 18, 2021 Life sciences company focusing on novel drug development and pharmaceutical MYND Life Sciences Inc. (OTCMKTS: MYNDF) announced that its wholly owned subsidiary MYND Diagnostics has started a clinical research of an evaluation proc...
Spotlight Stock,Trends & Articles Cybin’s Device to Evaluate Psychedelics’ Effects on the Brain Approved by the FDA By Dennis Mutua November 16, 2021 Pharmaceutical company focusing on advancing psychedelics therapies by utilizing drug discovery platforms and innovative drug delivery Cybin Inc. (NYSE American: CYBN) announced having secured an approval from U.S Food and Drug Ad...